2022-04-27 Redeye Orphan Drug Day Chief Medical Officer, Carl Bjartmar presents at Redeye Orphan Drug Day
2022-02-24 Erik Penser Bank – Life Science day Chief Commercial Officer Julie Waras Brogren presents at Erik Pensers Life Science day
2022-01-31 Ascelia Pharma – Aktiedagen in Lund 2022 Chief Commercial Officer presents at Aktiedagen in Lund
2022-01-20 Redeye Fight Cancer Seminar 2022 VP of R&D Andreas Norlin presents at Redeye Fight Cancer Seminar
2021-12-07 HC Andersen Capital seminar – Re-read Study Orviglance vs. Gadolinium CEO Magnus Corfitzen presents results from the re-read study vs. a gadolinium contrast agent (presentation in Danish)
2021-11-11 Redeye Life Science Day 2021 Ascelia Pharma CEO Magnus Corfitzen presents at Redeye Life Science Day.
2021-11-04 Q3 2021 Financial Presentation The Executive Managment in Ascelia Pharma presents a business update and the quarterly results
2021-10-06 HC Andersen/Nordea Small & Mid Cap Seminar CEO Magnus Corfitzen presents at the Danish HC Andersen/Nordea Small & Mid cap seminar (presentation in Danish)
2021-09-30 Erik Penser Bank – Orphan Drugs Day CEO Magnus Corfitzen presents how Ascelia Pharma advances orphan drugs
2021-09-28 Swedish Shareholders’ Association CMO Carl Bjartmar presents Ascelia Pharma at the Swedish Shareholders' Association's share day
2021-09-27 Clinical collaboration with Taiho Oncology CEO Magnus Corfitzen presents the clinical collaboration with Taiho Oncology (in Danish)
2021-06-16 HC Andersen Life Science Seminar CEO Magnus Corfitzen presents at HC Andersen Life Science Seminar (in Danish)
2021-03-31 HC Andersen presentation CEO Magnus Corfitzen presents the capital raise to be used for Orviglance commercial preparations and Oncoral clinical program
2021-01-21 Redeye Fight Cancer Seminar CMO Carl Bjartmar presents the company and how we fight cancer